Numinus Wellness Strives To Become Psychedelic Research Hub After Acquisition Of Novamind Inc.
In a year where M&A activity is expected to ratchet-up in 2022, Numinus Wellness Inc. (OTC: NUMIF) is among the first to take action.
Numinus To Acquire Novamind For $20.74M In Stock
Numinus Wellness Inc. (TSX:NUMI)(OTCQX:NUMIF) and Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) have entered into a definitive arrangement agreement pursuant to which…
Core One Labs Begins Trading On OTCQB
Under the CLABF symbol, psychedelics-oriented company Core One Labs (OTCQB:CLABF) started trading on the OTCQB Venture Market. The…
EXCLUSIVE: Bienstar Wellness Enters Brazilian Psychedelic Market, Will Acquire Ibogaine Co.
Bienstar Wellness Corp., an integrative mental health company specializing in psychedelic medicine with core operations in Latin America, has entered into a binding letter of intent to acquire 100% of BRC Saude Mental E Terapias Assistidas Ltda., a Brazilian psychedelic institution specialized in ibogaine treatment for substance ab
Novamind To Offer Psychedelic-Assisted Group Therapy
Novamind Inc. (OTCQB:NVMDF) has announced that it will offer a model of psychedelic-assisted group therapy. Under the name…
Psyched: MindCure Shuts Down Operations, Novamind And MindMed Partner For Study
The psychedelics space was shaken up on the news that MindCure Health (OTC:MCURF) was shutting down operations. After a…
Psyched: Albert Labs Goes Public, Ex-Moderna Executive Joins MAPS, Novamind and Usona Join For Phase 2 Psilocybin Trial
A new company has entered the public psychedelic markets, with an alternative drug-to-market approach. Using Real World Evidence trials,…
Novamind Stock Slightly Up On Grants Restricted Share Units
Novamind Inc. (OTCQB:NVMDF)(CSE:NM)(FSE:HN2) a mental health company specialized in psychedelic medicine, has granted an aggregate of 325,000 restricted…
Novamind To Conduct Phase II Psilocybin Trial For Major Depressive Disorder
Novamind Inc. (OTCQB:NVMDF) (CSE:NM)(FSE:HN2) will conduct a phase II clinical trial investigating psilocybin for major depressive disorder sponsored…
Benzinga Expands Footprint into the Psychedelic Industry with the Launch of the Benzinga Psychedelic Advisory Council
DETROIT, March 4, 2022 /PRNewswire/ -- The Benzinga Psychedelics Advisory Council is a collective of the leading minds and voices in the psychedelics space, composed of key thought leaders sharing insights into industry developments, sector trends and breaking news.